GI 2 Flashcards

1
Q

Congenital Pyloric stenosis EPIDIOMIOLOGY + CAUSES

A

M > F
-Genetic predisposition for children from affected parents
-Acquired pyloric obstruction, as a result of
chronic duodenal ulcer with scarring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Congenital Pyloric Stenosis PATHOPHYSIOLOGY + CLINICAL FINDINGS

A

Progressive hypertrophy of the circular muscular layer in the pyloric sphincter

Clinical findings:
 Projectile vomiting; not bile stained fluid  Palpable mass (“OLIVE”); epigastrium (70% cases)
 Obvious hyperperistalsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

GASTROPARESIS definitions

A

Decreased stomach motility, due to:
 Autonomic neuropathy (e.g. Diabetes Mellitus)
 Previous vagotomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

GASTROPARESIS clinical findings + treatments

A

Clinical findings:
 Early satiety and bloating
 Vomiting of undigested food

Treatment:
 Frequent, small meals
 Metoclopramide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Acute Gastritis CLINICAL FEATURES

A

Asymptomatic disease, or
Variable degrees of epigastric pain, nausea
and vomiting, or
More severe cases: Mucosal erosion,
ulceration, haemorrhage, haematemesis,
melena, or massive blood loss (rarely)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Microscopic findings:
Mild Acute Gastritis:
Moderate oedema and slight vascular
congestion in the lamina propria Intact surface epithelium Scattered neutrophils, intraepithelial

More severe mucosal damage:
Erosion or loss of superficial epithelium
Formation of mucosal neutrophilic infiltrates
and purulent exudates Occurrence of haemorrhages
Acute Erosive Haemorrhagic Gastritis: Con-
current presence of erosion and haemorrhage

A

Acute Gastritis:
 Microscopic findings:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acute Erosive Haemorrhagic Gastritis:
Causes + Clinical findings

A

Causes: NSAID, alcohol, H. Pylori, smoking,
severe burn (Curling ulcer), CNS injury
(Cushing ulcer)

Clinical findings:
Haematemesis Melena Iron deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Type A Chronic Atrophic Gastritis =
Autoimmune Gastritis:
Definition +localisation +complications

A

‘Abs to parietal cells (produce HCl and
intrinsic factor) and intrinsic factor (necessary for the absorption of Vit. B12 [Cobalamin])
Development of Pernicious anaemia
Localisation: Body and fundus

Association/Complications:
 Achlorhydria with Hypergastrinaemia
 Vit. B12 deficiency => Macrocytic anaemia
 ↑ Risk for gastric Adeno-Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Type B Chronic Atrophic Gastritis =
H. Pylori (causes) associated Gastritis:

CLINICAL FINDINGS + COMPLICATIONS/ ASSOCIATIONS + localisation

A

-Localisation: Antrum and pylorus
Clinical findings: Increased gastric acid
secretion
Complications/Associations: Gastric and
duodenal peptic ulcers, gastric Adeno-
Carcinoma and Lymphoma (MALT-type)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Type B Chronic Atrophic Gastritis =
H. Pylori associated Gastritis:

Pathophysiology:

A

Production of urease, protease
 Conversion of amino groups in proteins to
ammonia, by Urease
 Development of Chronic Gastritis and peptic
ulcer by the action of secretion products
Colonisation of mucous layer lining without
invasion of the wall
 Attachment to blood group O receptors on
mucosal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Microscopic findings:
Chronic inflammatory infiltrate in the
lamina propria
Intestinal metaplasia (similar to Barrett
Oesophagus) => Progression to Adeno-Ca

A

Type B Chronic Atrophic Gastritis =
H. Pylori associated Gastritis:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ACUTE PEPTIC ULCER
Cause

A

Complication of therapy with NSAIDs or
due to severe physiologic stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ACUTE PEPTIC ULCER
Types of Ulcer (associated with stress factors):

A

. Stress Ulcers: Critically ill patients with shock,
sepsis or severe trauma
. Curling Ulcers: Proximal duodenum; Severe
burns or trauma
.Cushing Ulcers: Stomach, duodenum, or
oesophagus; Individuals with intracranial
disease; Increased rate of perforation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pathogenesis
. NSAID-induced ulcers:
Direct chemical irritation + Cyclooxygenase
inhi-bition =>Prevention of Prostaglandin
synthesis => Elimination of Prostaglandin‟s
protective effect
Prostaglandin’s protective effect: Enhanced
bicarbonate secretion and ↑ vascular perfusion

Ulcers associated with brain injury:
Direct stimulation of vagal nuclei =>Gastric
acid hypersecretion

Ulcers associated with critically ill patients:
Systemic acidosis =>Decrease in intracellular
pH of mucosal cells =>Mucosal injury

A

ACUTE PEPTIC ULCER
Pathogenesis:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Macroscopic features:
 Acute Ulcers:
Round; Size: <1cm Ulcer base: Brown to black
 Acute Stress Ulcers:
Sharply demarcated Normal adjacent mucosa

 Microscopic findings:
Layers of Ulcer:
-Necrotic debris
-Mainly, neutrophilic infiltration

A

’, ACUTE PEPTIC ULCER

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ACUTE PEPTIC ULCER
Clinical features + complications + treatment

A

Clinical features:
 Nausea
 omiting
 Haematemesis

Complications:Perforation

Treatment:
 Proton pump inhibitors
 Histamine H2 receptor antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Peptic. Ulcer. Disease
CAUSES + epidemiology

A

‘ Causes: H. pylori infection (most common);
NSAID use
Epidemiology: Lifetime risk for development of an ulcer: 10% for Males and 4% for Females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Peptic ulcer disease location

A

-Gastric antrum and first portion of duodenum

-Oesophagus: Result of GOERD, ectopic gastric
mucosa
-Small intestine: Gastric heterotopia within a
Meckel diverticulum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Peptic ulcer disease Pathogenesis

A

 Imbalance btw mucosal defenses and
offensive agents  Chronic Gastritis  Peptic ulcer disease
 H. pylori infection. (Gastric hyperacidity)
 Parietal cell hyperplasia (GH)
 Excessive secretory responses. (GH)
 Impaired inhibition of stimulatory (GH)
mechanisms (e.g. Gastrin release)
 Chronic renal failure and hyperparathyroidism =>↑ Gastrin production (GH)
 Uncontrolled release of Gastrin (Zollinger-Ellison syndrome) => Multiple peptic ulcers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Macroscopic features:
 Lesions: <0.3 cm  Shallow; 0.6 cm  Deep
 Round to oval
 Sharply punched out defect
 Base: Smooth and clean

Microscopic findings:
 Base: Rich vascular granulation tissue
infiltrated with mononuclear leukocytes and a fibrous or collagenous scar
 Possible involvement of the entire thickness
of the wall by scarring

A

PEPTIC ULCER DISEASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

PEPTIC ULCER DISEASE Clinical features

A

Clinical features:
 Epigastric burning or aching pain
 Bloating and belching
 Iron deficiency anaemia
 Frank haemorrhage
 Perforation
 Occurrence of pain: 1-3 hours after meals
(during the day) and worse at night  Relief of pain: Intake of alkali or food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

PEPTIC ULCER DISEASE

Treatment

A

-Antibiotics (H. pylori)
-Proton pump inhibitors => Neutralisation of
gastric acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

MENETRIER DISEASE
-Hypertrophic or Hyperplastic
Gastropathy, Giant Hypertrophic Gastritis, and
Giant Hypertrophy of Gastric rugae

CRITERIA for DIAGNOSIS

A

Giant mucosal folds, involving the corpus and possibly antrum
Low acid production, even after stimulation
Mucosal protein loss
Histologic findings of corpus foveolar hyperplasia and glandular atrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Macroscopic features:
 Markedly hypertrophic rugae, resembling
cerebral convolutions
 Abrupt transition between normal and diseased
mucosa
 Typical form of the disease: Diffuse involvement
of the fundic portion, with sparing of the antrum
 Localised form of the disease: Well-circum-
scribed cerebroid mass either in the fundus or
the antrum

A

‘MENETRIER DISEASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
: Microscopic findings:  On the surface of the folds: Gastric foveolae enormously elongated, sometimes with a corkscrew (tortuous) appearance (foveolar hyperplasia)  Often, cystic dilation with mucous accumulation  Extension of cysts into the deeper mucosal layers and even occasionally the submucosa  Reduction of the glandular component (corpus gland atrophy)  Frequently, presence of non-specific inflammation in the superficial mucosa
MENETRIER DISEASE .
26
MENETRIER DISEASE Clinical features:
Hypochlorhydria or achlorhydria and often impressive hypoproteinaemia
27
MENETRIER DISEASE Management
 Adults: Fully developed disease is progressive and requires subtotal gastrectomy  Paediatric cases of so-called Ménétrier Disease are of the type that spontaneously resolve (self-limited disease)
28
Gastric polyps is what ?
Neoplasm of stomach
29
Gastric polyps. Pathogenesis: Develop as a result of:
-Epithelial or stromal cell hyperplasia  Inflammation  Ectopia  Neoplasia
30
Gastric polyps definition
 Definition: Nodules or masses that project above the level of the surrounding mucosa
31
Gastric polyps TYPES
Types of polyps:  Hyperplastic polyps  Inflammatory polyps  Fundic gland polyps  Adenomas
32
-INFLAMMATORY & HYPERPLASTIC POLYPS Pathogenesis
Chronic gastritis➡️ Injury and reactive hyperplasia ➡️Development of polyp
33
Macroscopy:  Ovoid lesions; Size: <1cm; Smooth surface  Microscopy:  Irregular, cystically dilated and elongated foveolar glands  Oedematous lamina propria  Acute and chronic inflammation  Surface erosions (may be present)
INFLAMMATORY & HYPERPLASTIC POLYPS
34
FUNDIC GLAND POLYPS Epidemiology
Epidemiology  Sporadic occurrence  Persons with Familial Adenomatous Polyposis
35
FUNDIC GLAND POLYPS . Cause/Pathogenesis:
Cause/Pathogenesis:  Proton pump inhibitors  Reduced acidity  Increased Gastrin secretion  Glandular hyperplasia
36
FUNDIC GLAND POLYPS Clinical features:
'Clinical features:  Nausea; Vomiting; Epigastric pain
37
Macroscopy: Well-circumscribed polyps in the gastric body and fundus Microscopy:  Cystically dilated, irregular glands  Lining of the glands: Flattened parietal and chief cells .
FUNDIC GLAND POLYPS
38
-Epidemiology:  10% of all gastric polyps  Mostly, sessile and growth in tubulo-villous or pure villous pattern; pure pedunculated tubular lesions are rare  Ages: 50-60 yrs.; M:F = 3:1
'GASTRIC ADENOMA
39
GASTRIC ADENOMA Cause/Pathogenesis:
Cause/Pathogenesis:  Chronic gastritis➡️ Atrophy and intestinal metaplasia
40
GASTRIC ADENOMA Risk for malignant transformation:
Risk for malignant transformation:  Dependent on lesion‟s size (risk elevated with lesions >2cm)  Presence of Adeno-CAs in up to 30% of gastric adenomas
41
Microscopic features:  Histologically, two types: Adenomas with intestinal differentiation (Goblet cells and/or Paneth cells) Adenomas with gastric differentiation (Columnar cells containing neutral mucin)  Epithelial dysplasia, classified as: Low-grade: Enlargement, elongation and hyper- chromasia of nuclei, epithelial crowding, pseudo- stratification High-grade: More severe cytologic atypia and irregular architecture (glandular budding, gland-within-gland, cribriform pattern)
Gastric adenoma
42
GASTRIC ADENOMA Localisation:
Localisation: Antrum of the stomach
43
ZOLLINGER ELLISON SYNDROME Cause
Caused by gastrin-secreting tumours, Gastrinomas
44
ZOLLINGER ELLISON SYNDROME Localisation:
>80% of Gastrinomas arise within the triangle defined as the confluence of the cystic and common bile duct superiorly, the second and third portions of the duodenum inferiorly, and the neck and body of the pancreas medially
45
ZOLLINGER ELLISON SYNDROME Epidemiology and Genetics:
Epidemiology and Genetics:  75% of patients = Sporadic, solitary tumours; Surgical resection  25% of pts. = Association with Multiple Endocrine Neoplasia type I (MEN type I); Multiple tumours or metastatic disease; Somatostatin analogues
46
ZOLLINGER ELLISON SYNDROME  Clinical manifestations
-Duodenal ulcers or chronic diarrhoea
47
ZOLLINGER ELLISON SYNDROME . Pathological findings within Stomach:
'Pathological findings within Stomach:  5x increase in number of parietal cells => Doubling of oxyntic mucosal thickness  Hyperplasia of mucous neck cells, mucin hyperproduction  Proliferation of endocrine cells => Small dysplastic nodules (sometimes), true Carcinoid Tumours (rarely)
48
ZOLLINGER ELLISON SYNDROME Diagnostic procedures:
.. Diagnostic procedures:  Somatostatin Receptor Scintigraphy  Endoscopic Ultrasonography
49
ZOLLINGER ELLISON SYNDROME Treatment:
Treatment: Blockade of acid hypersecretion:  Proton pump inhibitors or  High-dose H2 histamine receptor antagonists
50
ZOLLINGER ELLISON SYNDROME Progression:
Progression:  In general, slow growing tumours  60-90% of Gastrinomas are malignant
51
CARCINOMA OF THE STOMACH Epidemiology:
Epidemiology:  Most common after 50 yrs.  Men > Women  Most frequent occurrence in blood group A persons
52
CARCINOMA OF THE STOMACH Aetiologic factors
Aetiologic factors: '. -H. pylori - Nitrosamines from dietary amines and nitrites used in food preservatives. Smoked fish (Japan) -Excessive salt intake and diet low in fresh fruits and vegetables -Achlorhydria and Chronic Gastritis +/- Pernicious Anaemia -Menetrier disease (Giant Hypertrophic Gastritis)  Familial cases associated with mutations to E-Cadherin gene (CDH1): . -Diffuse infiltrating signet-ring cell CAs -Patients with these mutations =>. Development of lobular CA of the breast -Patients with Lynch syndrome (Hereditary Non-Polyposis Colorectal Cancer) => Increased risk for gastric CA
53
-CARCINOMA OF THE STOMACH  Pathogenesis: Mutations:
. Mutations: Germline mutations in CDHI (encodes E-Cad- herin); Protein contributing to epithelial inter- cellular adhesion; Loss of E-Cadherin function =>Development of diffuse type gastric cancer Germline mutations in Adenomatous Polyposis Coli (APC) genes (patients with FAP) => Increased risk of intestinal type gastric cancer Acquired mutations of β-Catenin = Sporadic intestinal type gastric cancer TP53 mutations = Majority of sporadic gastric cancers of both histologic types
54
CARCINOMA OF THE STOMACH  Pathogenesis (cont.): H. pylori:
Pathogenesis (cont.):  H. pylori: H. pylori induced Chronic Gastritis => Increased production of pro-inflammatory proteins (IL-1β and TNF) Polymorphisms related to enhanced production of these cytokines => Intestinal-type gastric CA
55
CARCINOMA OF THE STOMACH  Pathogenesis (cont.): EBV:
EBV: EBV-positive tumours characterised by: 1.Localisation: Proximal stomach 2.Diffuse morphology 3,Marked lymphocytic infiltrate
56
Characteristics:  Localisation: Minor curvature of the antrum or pre-pyloric region => Spread to the adjacent organs, peritoneum, regional lymph nodes and liver  Distal sites: Virchow node: Supra-clavicular lymph nodes with metastasis of gastric CA Krukenberg tumours: Bilateral involvement of the ovaries by tumour metastasis; Tumour consisted of signet ring-cells
CARCINOMA OF THE STOMACH  Characteristics:
57
Macro-/Microscopic features: A. Intestinal type: Association with H. pylori Polypoid carcinoma; solid mass projecting into the lumen Possible, ulceration DD: Peptic Ulcer (smooth base, non-elevated punched out margins) vs. CA (Ulcer with irregular necrotic base and firm raised margins)
:. CARCINOMA OF THE STOMACH A. Intestinal type:
58
. Macro-/Microscopic features (cont.): Synonym: Linitis plastica, leather-bottle stomach NO association with H. pylori Macroscopy: Thickened, rigid stomach wall Microscopy: Diffuse signet-ring cells infiltrates with accompanying extensive fibrosis
CARCINOMA OF THE STOMACH Infiltrating or Diffuse CA:
59
LYMPHOMA OF THE STOMACH Cytogenetic abnormalities:
Cytogenetic abnormalities: (11;18) trans-location; Involvement of MALT1 and IAP2 genes; High predictive value, since its presence associated with unresponsiveness to: i. Antibiotic treatment and ii. Therapy with oral alkylating agents
60
Microscopic features:  Dense infiltrate of small lymphoid cells, often accompanied by scattered reactive lymphoid follicles  Lymphoid cells: Variable admixture of small lympho- cytes, centrocyte-like cells, and monocytoid cells  Common finding, focal or extensive plasmacytoid differentiation  Possible presence of „Dutcher bodies‟ (true intra- nuclear eosinophilic inclusions made up of immu- noglobulin)  Great diagnostic significance  Important diagnostic sign: Infiltration of the glandular epithelium by neoplastic lymphocytes, resulting in so-called „lympho-epithelial lesions‟
EXTRANODAL MARGINAL ZONE LYMPHOMA (MALT) Microscopic features:
61
LARGE B-CELL LYMPHOMA
-High-grade, aggressive lymphoma -Usually, in individuals over the age of 50 years
62
LARGE B-CELL LYMPHOMA Clinical manifestation:
Clinical manifestation: Large palpable mass (and still excellent physical condition of the patients)
63
Macroscopic findings: with a tendency to spare the pylorus  Large lobulated (sometimes polypoid) mass  Commonly, superficial or deep ulceration
LARGE B-CELL LYMPHOMA
64
LARGE B-CELL LYMPHOMA Preferred (predilection) localisation
Site of predilection: Distal half of the stomach, with a tendency to spare the pylorus
65
Microscopic features:  Most cases composed of cells resembling large non-cleaved cells (centroblasts) but with a slightly more abundant cytoplasm, sometimes resulting in a plasmablastic or immunoblastic appearance  Multinucleated cell forms resembling Reed- Sternberg cells may be present  The phenotypic features are those of B cells
LARGE B-CELL LYMPHOMA
66
Differential diagnosis w/ Undifferentiated CARCINOMA . Microscopic features favouring Lymphoma: Lack of continuity between epithelium and tumour cells  Lack of suggestion of an acinar pattern  Preservation of muscularis mucosae fibers  Immuno-cytochemical evaluation of lymphoid and epithelial markers in difficult cases
LARGE B-CELL LYMPHOMA
67
LARGE B-CELL LYMPHOMA Prognosis and Progression
Prognosis and Progression  Prognosis for gastric Large B-Cell Lymphoma, substantially better than for gastric Carcinoma  The overall 5-year disease-free survival rate: Approximately 60% Favourable prognostic features: Small tumour size Superficial mural invasion Absence of regional lymph node involvement .
68
CARCINOID TUMOURS Definition
Originate from endocrine organs (e.g. endocrine pan- creas) and neuroendocrine-differentiated GI epithelia (e.g. G-cells) as well as tracheo-bronhial tree and lungs
69
CARCINOID TUMOURS . Gastric Carcinoids are associated with: 
Gastric Carcinoids are associated with:  Endocrine cell hyperplasia  Chronic atrophic gastritis  Zollinger-Ellison syndrome
70
CARCINOID TUMOURS . Grading based mainly on:
Grading based mainly on:  Mitotic index  Ki-67 immuno-positive cells (%)
71
Macroscopic features:  Intramural or submucosal masses => Small polypoid lesions  Yellow or tan in appearance  Intense Desmoplasia => Kinking of the bowel and obstruction Microscopic findings:  Arrangement of the cells in: i. Islands, ii. Glands, iii. Trabeculae, iv. Strands, or v. Sheets  Cells: Scant, pink granular cytoplasm Round to oval stippled nucleus
CARCINOID TUMOURS
72
CARCINOID TUMOURS Immunohistochemistry
Immunohistochemistry: Neuron-Specific Enolase (NSE), Chromogranin, Synaptophysin
73
CARCINOID TUMOURS Clinical features:
Clinical features:  Symptoms depend on hormones produced by the Tm Carcinoid Syndrome: Cause: Secretion of vasoactive substances (e.g. kinins, VIP, angiotensin II, (nor)epinephrine, etc.) Clinical picture: Cutaneous flushing Sweating Bronchospasm Colicky abdominal pain Diarrhoea
74
CARCINOID TUMOURS Prognosis:
Prognosis: Depends primarily on tumour‟s location: Foregut Carcinoid Tumours: Oesophagus, Stomach, Duodenum Rarely, metastases Gastric carcinoids develop as a result of prolonged Gastrin hypersecretion in Zollinger Ellison syndrome Midgut Carcinoid Tumours: Jejunum, Ileum Multiple and aggressive Poor outcome: i. Depth of local invasion, ii. Increased size, iii. Necrosis, and iv. Mitosis Hindgut Carcinoids: Appendix vermiformis (benign), Colorectum Incidentalomas Rectal Carcinoids: Abdominal pain and weight loss Occasionally, metastases
75
GASTRO-INTESTINAL STROMAL TUMOUR (GIST)
Mesenchymal tumours, derived from pacemaker (myenteric interstitial) cells of Cajal Most common mesenchymal tumour of the abdomen
76
GASTRO-INTESTINAL STROMAL TUMOUR (GIST) Localisation
Localisation: Submucosa of stomach, small and large intestine and extra-gastrointestinal sites
77
GASTRO-INTESTINAL STROMAL TUMOUR (GIST) Pathogenesis
Pathogenesis:  75-80% of GISTs: Oncogenic, gain-of-function mutations of the gene encoding the tyrosine kinase c-KIT  8% of GISTs: Activating mutations of PDGFRA
78
Macroscopic features:  Primary lesions: Solitary, well circumscribed, fleshy submucosal masses  Metastases: Multiple small serosal nodules or fewer nodules in the liver Microscopic features:  Thin, elongated spindle cells or  Plumper epithelioid cells  c-KIT (CD117) immuno-positivity in 95% of GISTs
GASTRO-INTESTINAL STROMAL TUMOUR (GIST)
79
GASTRO-INTESTINAL STROMAL TUMOUR (GIST) Clinical features:
Clinical features: Symptoms are related to: Mass effect Mucosal ulceration
80
GASTRO-INTESTINAL STROMAL TUMOUR (GIST) Prognosis
Prognosis, correlates with:  Tumour size  Mitotic Index (MI)  Location  Gastric GISTs less aggressive than small- intestine GISTs  Gastric GISTs: Recurrence or metastasis: <5cm tumours  Rare; >10cm and high MI <=> Common
81
HERNIATION Definition
Definition: Any weakness or defect in the wall of the peritoneal cavity may permit protrusion of a serosa-lined pouch of peritoneum called hernia sac
82
HERNIATION. Localisation
Lo'calisation: Occurrence of acquired hernias most commonly anteriorly (inguinal and femoral canals or umbilicus, or at sites of surgical scars)
83
HERNIATION Complications:
Complications:  Visceral protrusion (external herniation)  Inguinal hernias (mostly with narrow orifices and large sacs): Entrapment of small bowel loops or portions of omentum => Pressure at the neck of the pouch => Impairment of venous drainage of the entrapped viscous => Stasis and oedema=> Increase in the bulk of the herniated loop => Permanent entrapment or incarceration => Over time, arterial and venous compromise (strangulation) => Infarction
84
ADHESIONS Causes
. Causes:  Congenital  Acquired: Surgical procedures, infection or other causes of peritoneal inflammation, such as endometriosis '
85
ADHESIONS Complications
Complications: Development of closed loops through which other viscera may slide => Entrapment => Internal herniation => Obstruction and strangulation
86
'VOLVULUS Definition + clinical presentation
Complete twisting of a loop of bowel about its mesenteric base of attachment, which produces both luminal and vascular compromise  Clinical presentation: Features of obstruction and infarction
87
VOLVULUS Localisation
-Localisation: Large redundant loops of sigmoid colon (most often), caecum, small bowel, stomach, or transverse colon (rarely)
88
INTUSSUSCEPTION
Condition by which a segment of the intestine, constricted by a wave of peristalsis, telescopes into the immediately distal segment
89
INTUSSUSCEPTION ,. Progression:
'Progression: Once trapped, the invaginated segment is propelled by peristalsis and pulls the mesentery along
90
INTUSSUSCEPTION Causes
Causes:  Infants and children: In some cases, association with Rotavirus infection  Older children and adults: Intraluminal mass or tumour (serves as the point of traction)
91
INTUSSUSCEPTION Complications:
Complications: Untreated intussusception may progress to intestinal obstruction, compression of mesenteric vessels and infarction
92
INTUSSUSCEPTION , Management
Management:  Infants and young children: Barium enema (effectively reduces the intussusception)  Older patients: Surgical interventio
93
ISCHAEMIC BOWEL DISEASE Classification of ischaemic damage to bowel:
Classification of ischaemic damage to bowel:  Mucosal infarction: Up to muscularis mucosae  Mural infarction of mucosa and submucosa  Trans-mural infarction: All three layers of the wall
94
ISCHAEMIC BOWEL DISEASE . Causes
Causes:  Acute or chronic hypo-perfusion => Mucosal or mural infarctions  Acute vascular obstruction => Trans-mural infarction
95
ISCHAEMIC BOWEL DISEASE Causes of acute arterial obstruction:
Causes of acute arterial obstruction:  Severe atherosclerosis  Aortic aneurysm  Hypercoagulable states  Oral contraceptives  Embolisation of cardiac vegetations or aortic atheromas
96
ISCHAEMIC BOWEL DISEASE Causes of intestinal hypoperfusion:
Causes of intestinal hypoperfusion:  Cardiac failure  Shock  Vasculitides (PAN, Henoch-Schönlein purpura, Wegener granulomatosis, etc.)
97
ISCHAEMIC BOWEL DISEASE Pathogenesis:
Pathogenesis: Phases of intestinal responses to ischaemia: First phase: Occurrence of initial hypoxic injury at the onset of vascular compromise . Second phase: Reperfusion injury;Due to increased permeability of capillaries and arterioles => Increase of diffusion and fluid filtration across the tissues, free radical production, neutrophil infiltration and release of inflammatory mediators Severity of ischaemic bowel disease depends on: -Time frame for its development -Severity of vascular compromise -Affected vessels Intestinal vascular anatomy contributes to distribution of ischaemic damage: 1. Watershed zones: Intestinal segments particularly susceptible to ischaemia; These are: Splenic flexure, Sigmoid colon and Rectum 2. Morphologic configuration of intestinal capillaries allows good blood supply of crypts but leaves epithelial cells vulnerable to ischaemia
98
Macroscopic features:  Distribution of lesions: Segmental and irregular  Haemorrhagic and ulcerated mucosa  Oedema induced thickening of the wall  Severe disease (e.g. Acute arterial thrombosis => Transmural infarction): Extensive mucosal and submucosal haemorrhage and necrosis; Coagulative necrosis of muscularis propria (1-4 days) => Purulent serositis => Perforation
ISCHAEMIC BOWEL DISEASE
99
Microscopic findings:  Atrophy or sloughing of surface epithelium  Hyper-proliferative crypts  Recruitment of neutrophils within hours of reperfusion  Acute phases of ischaemia: Bacterial super- infection and enterotoxin release => Pseudo- membrane formation  Chronic ischaemia: Fibrous scarring of the lamina propria, and less common stricture
ISCHAEMIC BOWEL DISEASE
100
ISCHAEMIC BOWEL DISEASE Clinical Features
Clinical Features:  Sudden, severe abdominal pain  Tenderness  Nausea and Vomiting  Bloody diarrhoea or melaena (“tarry” feces) => Vascular collapse and shock (due to blood loss)  Decline or disappearance of peristaltic sounds  Muscular spasm =>Board-like rigidity of the abdominal wall
101
ISCHAEMIC BOWEL DISEASE DD
DD: Acute appendicitis, perforated ulcer, acute cholecystitis
102
ISCHAEMIC BOWEL DISEASE . Complications
Complications: Break down of mucosal barrier => Bacteria enter the circulation => Sepsis
103
ANGIODYSPLASIA
Characterised by malformed submucosal and mucosal blood vessels
104
ANGIODYSPLASIA Localisation
Localisation: Caecum or right Colon
105
ANGIODYSPLASIA Pathogenesis
Pathogenesis:  Normal bowel distention and contraction => Occlusion of the submucosal veins (penetrate through the muscularis propria) => Focal dilation and tortuosity of overlying submucosal and mucosal vessels  Caecum: Largest diameter of any colonic segment => Greatest wall tension => Development of angiodysplasias (preferable locus)  Age related degenerative vascular changes  Angiodysplasia has also been linked to aortic stenosis and Meckel diverticulum (congenital anomaly?)
106
Microscopic findings:  Ectatic nests of tortuous veins, venules, and capillaries  Separation of the vascular channels from the intestinal lumen, by only the vascular wall and a layer of attenuated epithelial cells; As a result of this: Limited injury of the vessel => Significant haemorrhage
ANGIODYSPLASIA
107
Malabsorption
Malabsorption: Characterised by defective absorption of fats, fat- and water-soluble vitamins, proteins, carbohydrates, electrolytes and minerals, and water
108
! MALABSORPTION Pathogenesis:
Pathogenesis: Malabsorption results from disturbance in at least one of the four phases of nutrient absorption: 1. Intraluminal digestion, in which proteins, carbohydrates, and fats are broken down into forms suitable for absorption 2. Terminal digestion, which involves the hydrolysis of carbohydrates and peptides by disaccharidases and peptidases, respectively, in the brush-border of the small intestinal mucosa 3. Transepithelial transport, in which nutrients, fluid and electrolytes are transported across and processed within the small intestinal epithelium 4. Lymphatic transport of absorbed lipids
109
MALABSORPTION Clinical features:
Clinical features:  Chronic malabsorption: Chronic diarrhoea, weight loss, anorexia, abdominal distention, borborygmi*, and muscle wasting  Hallmark of malabsorption <=> Steatorrhoea (excessive faecal fat and bulky, frothy, greasy, yellow or clay-coloured stools) * Borborygmus: A rumbling or gurgling noise made by the movement of fluid and gas in the intestines
110
MALABSORPTION SYNDROMES Similarities among the various Malabsorption Syndromes
General symptoms:  Diarrhoea  Flatus  Abdominal pain  Weight loss - Inadequate absorption of Vitamins and Minerals: Pyridoxine, folate, or Vitamin B12 deficiency => Anaemia and Mucositis Vitamin K deficiency => Bleeding Calcium, Magnesium, or Vitamin D deficiencies => Osteopenia and Tetany Vitamin A or B12 deficiencies => Peripheral Neuropathy
111
DIARRHOEA Definition:
'Definition: Increase in stool mass, frequency, or fluidity, typically greater than 200gr per day
112
DIARRHOEA Dysentery
'Dysentery: Painful, bloody, small-volume diarrhoea
113
Classification of diarrhoea
'. 1. Secretory diarrhoea:  Characterised by isotonic (with plasma) stool  Persists during fasting 2. Osmotic diarrhoea:  Typical in lactase deficiency  Due to the excessive osmotic forces exerted by unabsorbed luminal solutes  >50 mOsm more concentrated than plasma  Abates with fasting 3. Malabsorptive diarrhoea:  Result of generalised failures of nutrient absorption  Associated with steatorrhoea  Relieved by fasting 4. Exudative diarrhoea:  Due to inflammatory disease  Characterised by purulent, bloody stools  Continues during fasting
114
COELIAC DISEASE . Synonyms
Synonyms: Coeliac Sprue or Gluten-sensitive Enteropathy
115
COELIAC DISEASE . Causes
Causes: Immune-mediated enteropathy, triggered by the ingestion of Gluten-containing cereals (e.g. wheat, rye, barley) in genetically predisposed individuals
116
COELIAC DISEASE Predisposing factors:
Predisposing factors:  Class II HLA-DQ2 or HLA-DQ8 alleles  Association with: Type I Diabetes Mellitus, Thyroiditis, Sjögren syndrome, IgA nephro- pathy, Down syndrome and Turner syndrome
117
COELIAC DISEASE Pathogenesis:
Pathogenesis:  Digestion of Gluten into amino acids and peptides (Gliadin peptide; resistant to degradation by gastric, pancreatic and small intestinal proteases)  Deamidation of Gliadin by tissue trans- glutaminase  Interaction of deamidated Gliadin with APCs  Presentation of the former to the CD4+ T cells -Production of cytokines (IFNγ) by the latter (CD4+ T) => Tissue damage  B cell response: Production of the following Antibodies: Anti tissue trans-glutaminase (anti-tTG) Anti-deamidated Gliadin - Anti-endomysial -Deamidated Gliadin peptides induce epithelial cell to produce IL15  IL15 triggers activation and proliferation of CD8+ T cells  CD8+ T cells express NKG2D (MIC-A receptor) and become cytotoxic, thus kill enterocytes that express MIC-A  Tissue damage favours the movement of Gliadin across the epithelium => Perpetuation of the disease‟s cycle
118
COELIAC DISEASE Localisation
Localisation: Second portion of duodenum or proximal jejunum
119
'Microscopic findings:  Increased numbers of intraepithelial CD8+ T cells  Intraepithelial lymphocytosis  Crypt hyperplasia (Increased crypt mitotic activity => Limitation in differentiation ability of absorptive enterocytes => Defects in terminal digestion and trans-epithelial transport)  Villous atrophy (Loss of mucosal and brush- border surface area => Malabsorption)  Fully developed disease: Increased numbers of plasma cells, mast cells and eosinophils, within upper part of the lamina propria
COELIAC DISEASE
120
COELIAC DISEASE  Clinical Features: Silent coeliac disease + Latent coeliac disease
-Silent coeliac disease: Positive serology Villous atrophy Absence of symptoms - Latent coeliac disease: Positive serology Absent villous atrophy
121
COELIAC DISEASE Clinical Features (cont.):  Symptomatic adult coeliac disease:
Symptomatic adult coeliac disease: Anaemia (Iron, Vitamin B12 and folate deficiency) Diarrhoea Bloating Fatigue
122
COELIAC DISEASE Clinical features Pediatric coeliac disease: Classic symptoms;
Classic symptoms; 6-24 months Irritability Abdominal distention Anorexia Diarrhoea Failure to thrive Weight loss or muscle wasting
123
. Clinical Features (cont.):  Pediatric coeliac disease: Non-Classic symptoms (older children)
Abdominal pain Nausea Vomiting Bloating or constipation Pruritic blistering skin lesion (Dermatitis herpetiformis or Duhring's disease)
124
COELIAC DISEASE  Laboratory Findings:
Laboratory Findings:  IgA Abs to tissue trans-glutaminase  IgA or IgG Abs to deamidated Gliadin  Absence of HLA-DQ2 or HLA-DQ8 (high negative predictive value)
125
Coeliac-disease associated malignancies: .
Coeliac-disease associated malignancies:  Enteropathy-associated T Cell Lymphoma  Small intestinal Adenocarcinoma
126
TROPICAL SPRUE + epidemiology
Malabsorption syndrome Epidemiology:  Occurrence, almost exclusively in people living in or visiting the tropics  Generally endemic; although epidemics have been reported
127
-TROPICAL SPRUE Causes
Causes:  No definite causal organism  Overgrowth of aerobic enteric bacteria has been documented  Proposed aetiologic factors: Various infections, including Cyclospora or enterotoxigenic bacteria
128
. TROPICAL SPRUE Histologic findings
Histologic findings:  Similar to Coeliac disease, but:  Total villous atrophy <=> Uncommon in tropical sprue  Tropical Sprue involves the distal small bowel  Enlarged (megaloblastic) nuclei within epithelial cells (reminiscent of those seen in pernicious anaemia)
129
TROPICAL SPRUE Clinical features
Clinical features:  Malabasorption usually manifested within days or a few weeks of an acute diarrhoeal enteric infection  High frequency of folate or Vit. B12 deficiencies
130
AUTOIMMUNE ENTEROPATHY
X-linked disorder characterised by severe persistent diarrhoea and autoimmune disease MOSTLY IN YOUNG CHILDREN
131
AUTOIMMUNE ENTEROPATHY IPEX: Severe familial form
-Acronym for: Immune dysregulation Polyendocrinopathy ' Enteropathy X-linkage
132
AUTOIMMUNE ENTEROPATHY Causes
Causes: Germline mutation in the FOXP3 gene (located on the X chromosome)
133
AUTOIMMUNE ENTEROPATHY  Pathogenesis:
Pathogenesis:  FOXP3: Transcription factor expressed in CD4+ regulatory T cells  Individuals with IPEX and FOXP3 mutations => Defective T-regulatory function  Link between less severe forms of autoimmune enteropathy and other defects in regulatory T cell function
134
Microscopic findings:  Increased numbers of intraepithelial lymphocytes within the small intestine  Often, presence of neutrophils  Autoantibodies to enterocytes and goblet cells (common), antibodies to parietal or islet cells (in some cases)
. AUTOIMMUNE ENTEROPATHY
135
AUTOIMMUNE ENTEROPATHY Treatment
-Treatment:  Immunosuppressive medications (e.g. cyclo- sporine)  Bone marrow transplantation (in rare cases)
136
LACTASE (DISSACHARIDASE) DEFICIENCY Dissacharidases
. Dissacharidases: Located in the apical brush-border membrane of the villus absorptive epithelial cells .Biochemical defect  Unremarkable biopsy histology
137
Two types of lactase deficiency: 1. Congenital lactase deficiency: Cause + clinical + management
1. Congenital lactase deficiency:  Epidemiology & Genetics: Rare, autosomal recessive disorder  Cause: Mutation in the gene encoding lactase  Clinic: Explosive diarrhoea with watery, frothy stools and abdominal distention upon milk ingestion  Management: Termination of milk/milk products consumption, thus remove of the osmotically active, but unabsorbable lactose from the lumen
138
Acquired lactase deficiency: Cause + clinical
2. Acquired lactase deficiency:  Cause: Down-regulation of lactase gene expression  Disease presents after childhood  Onset of disease, sometimes associated with enteric viral or bacterial infections  Clinic: Abdominal fullness, diarrhoea, and flatulence, due to fermentation of the unabsorbed sugars by colonic bacteria; triggered by ingestion of lactose-containing dairy products
139
ABETALIPOPROTEINAEMIA
Rare autosomal recessive disease, characterised by an inability to secrete triglyceride-rich lipoproteins
140
'ABETALIPOPROTEINAEMIA Causes
Causes: Mutation in the Microsomal Triglyceride Transfer Protein (MTP) that catalyses transport of triglycerides, cholesterol esters, and phospholipids
141
-ABETALIPOPROTEINAEMIA Pathogenesis
Pathogenesis: MTP-deficient enterocytes unable to export lipoproteins and free fatty acids => Mono-glycerides cannot be assembled into chylomicrons => Buildup of triglycerides within the epithelial cells
142
ABETALIPOPROTEINAEMIA Microscopic findings + Histochemistry
Microscopic findings: Lipid accumulation in small intestinal epithelial cells Histochemistry: Oil red-O (demonstration of lipids)
143
ABETALIPOPROTEINAEMIA Clinical features:
Clinical features: Presentation in infancy:  Failure to thrive  Diarrhoea  Steatorrhoea
144
ABETALIPOPROTEINAEMIA Laboratory findings:
Laboratory findings:  Complete absence of all plasma lipoproteins containing apolipoprotein B  Failure to absorb essential fatty acids => Deficiencies of fat-soluble vitamins  Presence of acanthocytic red cells (burr cells) in peripheral blood smears, due to lipid membrane defects
145
'PSEUDOMEMBRANOUS COLITIS Synonym: Antibiotic-associated diarrhoea Cause
Cause: Clostridium difficile; 20% present in hospitalised adults
146
-PSEUDOMEMBRANOUS COLITIS Pathogenesis
Pathogenesis:  Prolonged intake of antibiotics => Disruption of the normal colonic microbiota => Overgrowth of C. difficile => Release of toxins => Ribosylation of small GTP-ases (Rho) => => Disruption of the epithelial cytoskeleton => Loss of tight junction barrier => Release of cytokines => Apoptosis
147
Macro-/Microscopic features:  Pseudo-membranes, consisting of an adherent layer of inflammatory cells and debris  Stripped surface epithelium  Lamina propria, with: Dense infiltrate of neutrophils Occasional fibrin thrombi within capillaries  Distention of damaged crypts by a mucopurulent exudate => “Eruption” to the surface, in a fashion reminiscent of a volcano
PSEUDOMEMBRANOUS COLITIS
148
PSEUDOMEMBRANOUS COLITIS Clinical Features:
. Clinical Features:  Fever  Leukocytosis  Abdominal pain  Cramps  Hypo-albuminaemia  Watery diarrhoea  Dehydration  Faecal leukocytes  Occult blood
149
'PSEUDOMEMBRANOUS COLITIS Diagnosis + Treatment
Diagnosis: Detection of C. difficile toxin Treatment: Metronidazole or Vancomycin
150
WHIPPLE DISEASE + cause
Rare, multi-visceral chronic disease Causative agent: Tropheryma whippelii (Gram [+] actinomycete)
151
WHIPPLE DISEASE Localisation
Localisation: Mesenteric lymph nodes, synovial membranes of affected joints, cardiac valves, brain, and other sites <=> Accumulation of bacteria-laden macrophages
152
Macroscopic features:  Shaggy gross appearance to the mucosal surface, due to villous expansion caused by the dense macrophage infiltrate  White to yellow mucosal plaques, due to lymphatic dilatation and mucosal lipid deposition
WHIPPLE DISEASE
153
Microscopic findings: Dense accumulation of distended, foamy macrophages in the small intestinal lamina propria
WHIPPLE DISEASE
154
Histochemistry: Periodic Acid-Schiff (PAS)- positive, diastase-resistant granules (represent lysosomes stuffed with partially digested bacteria), within macrophages
WHIPPLE DISEASE
155
WHIPPLE DISEASE Differential Diagnosis
Differential Diagnosis:  Intestinal Tbc (PAS [+] and acid-fast stain [+])  Whipple disease (PAS [+] but acid-fast stain [-]
156
WHIPPLE DISEASE Clinical symptoms:
Clinical symptoms: Accumulation of organism- laden macrophages within the small intestinal lamina propria and mesenteric lymph nodes => Lymphatic obstruction (impaired lymphatic transport) => Malabsorptive diarrhoea
157
WHIPPLE DISEASE Clinical presentation: Triad of:
 Diarrhoea  Weight loss  Malabsorption
158
WHIPPLE DISEASE Extra-intestinal symptoms:
Extra-intestinal symptoms:  Arthritis and arthralgia  Fever  Lymphadenopathy  Neurologic, cardiac, or pulmonary disease